Find clinical trials for Lymphoma in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma

Leukemia

Non-Hodgkin Lymphoma

Lymphoid Leukemia

Diffuse Large B-Cell Lymphoma

Precursor Cell Lymphoblastic Leukemia-Lymphoma

B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Phoenix, AZ, USA:

Locations recently updated

A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)

The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...

Enrolling

Lymphoma, Non-Hodgkin

Drug: Obinutuzumab

Drug: CC-99282

Phase 1, Phase 2

Celgene

Scottsdale, Arizona, United States and 89 other locations

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL)....

Enrolling

T-cell Lymphoma

Cutaneous T-cell Lymphoma

Drug: Fenretinide

Phase 1

SciTech Development

Scottsdale, Arizona, United States and 8 other locations

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

treatment of advanced classical Hodgkin lymphoma(HL)...

Active, not recruiting

Hodgkin Lymphoma

Drug: vinblastine

Drug: brentuximab vedotin

Phase 3

Takeda

Gilbert, Arizona, United States and 215 other locations

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma (RELATIVITY-069)

and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma...

Enrolling

Lymphoma, Non-Hodgkin

Hodgkin Disease

Drug: Relatlimab

Drug: Nivolumab

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)

Phoenix, Arizona, United States and 75 other locations

Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma (ALPHA)

of ALLO-501 in adults with relapsed or refractory large B-cell lymphoma or follicular lymphoma after a lymphodepletion regimen comp...

Active, not recruiting

Relapsed/Refractory Follicular Lymphoma

Relapsed/Refractory Large B Cell Lymphoma

Genetic: ALLO-501

Drug: Fludarabine

Phase 1

Allogene Therapeutics

Gilbert, Arizona, United States and 6 other locations

Locations recently updated

A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma (GOLSEEK-2)

to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...

Enrolling

Lymphoma, Follicular

Drug: Golcadomide

Drug: Doxorubicin

Phase 2

Celgene

Phoenix, Arizona, United States and 67 other locations

A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas

or obinutuzumab) in subjects with relapsed or refractory (R/R) lymphoma. Subjects must have received at least 2 prior lines of therapy, and ...

Active, not recruiting

Lymphoma

Drug: CC-220

Drug: Rituximab

Phase 1

Celgene

Phoenix, Arizona, United States and 25 other locations

First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma (EPCORE™ NHL-1)

The purpose of this trial is to measure the following in participants with relapsed and/or refractory B-cell lymphoma who receive epcoritama...

Active, not recruiting

Small Lymphocytic Lymphoma (SLL)

Marginal Zone Lymphoma (MZL)

Biological: Epcoritamab

Phase 1, Phase 2

Genmab

Phoenix, Arizona, United States and 84 other locations

Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

dosages in subjects with Relapsed/Refractory (r/r) Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM). Cemsidomide may be administered as...

Enrolling

Lymphoma, Non-Hodgkin's

Multiple Myeloma

Drug: Dexamethasone Oral

Drug: cemsidomide

Phase 1, Phase 2

C4 Therapeutics

Phoenix, Arizona, United States and 12 other locations

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

2 cohorts to assess safety and efficacy of emavusertib in combination with ibrutinib in participants with R/R primary central nervous system lymphoma...

Enrolling

Refractory Primary Central Nervous System Lymphoma

Relapsed Primary Central Nervous System Lymphoma

Drug: Emavusertib

Drug: Ibrutinib

Phase 1, Phase 2

Curis

Phoenix, Arizona, United States and 42 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Lymphoma in .css-epvm6{white-space:nowrap;}Phoenix, AZ

Related conditions:

Lymphoma trials near Phoenix, AZ, USA:

A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma (RELATIVITY-069)

Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma (ALPHA)

A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma (GOLSEEK-2)

A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas

First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma (EPCORE™ NHL-1)

Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Find clinical trials for Lymphoma in Phoenix, AZ